Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?

doi:10.1016/j.jmii.2021.01.012

Journal of Microbiology, Immunology and Infection

Volume 54, Issue 5, October 2021, Pages 997-1000

https://doi.org/10.1016/j.jmii.2021.01.012 Get rights and content

Under a Creative Commons license

open access

Abstract

Among 275 patients with COVID-19, we found that median blood zinc level was significantly lower in patients with poor clinical outcome (N = 75) as compared to patients with good clinical outcome (N = 200) (840 μg/L versus 970 μg/L; p < 0.0001), suggesting that zinc supplementation could be useful for patients with severe COVID-19.

Keywords

Zinc

SARS-COV-2

Severe

Clinical outcome

Chloroquine

Azithromycin

Journal of Microbiology, Immunology and Infection

Short CommunicationLow blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?

Abstract

Keywords

Short Communication
Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?